These immune signatures, although not directly linked to cognition or CRHR1 in the existing literature, support the broader hypothesis that immune dysregulation interacts with genetic predisposition in shaping neuropsychiatric symptoms after COVID-19. Here, CRHR1 is linked to COVID-19.